Sugar Editorial Picks
Oct 01, 2007 -
More than 20 years ago, two organizations created a partnership to increase breast cancer awareness. The partnership has grown to include a number of national public service organizations, professional medical associations, and government agencies all working together to build awareness of the disease, share information and provide access to screening services for countless women.
They claimed October as their month to highlight the issue, so today, Oct.
- 8 Comments
Other Search Results
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Risk Factors
- Prevention and Lifestyle Fa...
- Symptoms
- Diagnosis
- Prognosis
- Treatment
- Surgery
- Radiation
- Medications
- Chemotherapy
- Hormone Therapy
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approvals
- In September 2007, Evista (raloxifene) was approved for prevention of breast cancer in postmenopausal women with osteoporosis, and postmenopausal women at high risk for invasive breast cancer. Raloxifene and tamoxifen are the only two drugs approved for breast cancer prevention in high-risk women.
- In March 2007, lapatinib (Tykerb) was approved in combination with capecitabine (Xeloda) for treatment of advanced HER2-positive breast cancer.
- In November 2006, trastuzumab (Herceptin) was approved for treatment of early-stage HER2-positive breast cancer. Trastuzumab is also approved for advanced HER2-positive breast cancer.
Screening
- The American College of Physicians’ 2007 guidelines recommend that women with a low risk for breast cancer talk to their doctor before starting to have mammogram screening at age 40.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Symptoms
- Causes
- Prevention
- Diagnosis
- Prognosis
- Treatment
- Surgery
- Medications
- Radiation Therapy
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Ovarian Cancer Symptoms
Even early-stage ovarian cancer can produce symptoms, according to a 2007 consensus statement issued by the American Cancer Society, the Gynecologic Cancer Foundation, and the Society of Gynecologic Oncologists. Because ovarian cancer can grow very rapidly, early detection is extremely important. Contact your doctor (preferably a gynecologist) if you experience these symptoms on a daily basis for more than a few weeks:
- Bloating
- Pelvic or abdominal pain
- Difficulty eating or feeling full quickly
- Urgent or frequent urination
Hormone Replacement Therapy (HRT) Increases Ovarian Cancer Risk
- Post-menopausal women who use hormone replacement therapy (HRT) for more than 5 years are 20% more likely to develop ovarian cancer than women who do not use HRT, suggests a 2007 study in the Lancet.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Dietary Factors
- Prevention
- Diagnosis
- Staging
- Prognosis
- Surgery
- Medications
- Radiation Treatment
- Follow-up Testing
- Treatment for Metastasized ...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In September 2006, the Food and Drug Administration approved panitumumab (Vectibix) for the treatment of patients with colorectal cancer that has spread to other parts of the body following chemotherapy. Like cetuximab (Ertibux), panitumumab targets the epidermal growth factor receptor (EGFR) on cancer cells. Panitumumab is the first new colorectal cancer drug approved since 2004.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Lifestyle Changes
- Diagnostic Tests
- Staging Systems
- Surgical Procedures
- Radiation Treatments
- Treatment Options by Stages...
- Chemotherapy Treatments
- Investigative Agents
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Research News:
- About 3,000 nonsmokers die each year of lung cancer resulting from exposure to secondhand smoke, according to a 2006 Surgeon General report.
- Advexin, a genetic therapy that contains the p53 tumor-suppressor gene, is showing promise. A 2006 study in Japan found that out of 13 patients with advanced NSCLC receiving Advexin, 10 had stabilized. Advexin is in Phase II clinical trials for NSCLC.
- Studies are finding that NSCLC tumors in people who never smoked have a much higher rate of epithelial growth-factor receptor (EGFR) mutations.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Melanoma
- Nonmelanoma Skin Cancer
- Precancerous Skin Condition...
- Causes
- Risk Factors
- Prevention
- Screening
- Diagnosis
- Staging
- Treatment for Melanoma
- Treatment for Nonmelanoma S...
- Prognosis
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Risk factors
According to a report in the Archives of Dermatology, marathon runners are more likely than the general population to develop skin changes that increase the risk for melanoma.
Prevention
A study published in The Lancet indicates that the best ways to avoid sun damage are to reduce the time you spend in the sun and to wear a hat and clothing to protect as much of your skin as possible. Fabrics that are thick and tightly woven offer the best protection.
- 0 Comments
Sep 03, 2008 -
Overview
- Definition
- Alternative Names
- Causes, incidence, and risk factors
- Symptoms
- Signs and tests
- Treatment
- Support Groups
- Expectations (prognosis)
- Complications
- Calling your health care provider
- Prevention
- References
Illustrations
Female Breast
Needle biopsy of the breast
Open biopsy of the breast
Breast self-exam
Breast self-exam
Breast self-exam
Mammary gland
Sentinel node biopsy
Mastectomy - series
Breast lump removal - series
HEALTH GUIDE REFERENCE FROM A.D.A.M
Definition
Breast cancer is a cancer that starts in the tissues of the breast.
There are two main types of breast cancer:
- Ductal carcinoma starts in the tubes (ducts) that move milk from the breast to the nipple. Most breast cancers are of this type.
- Lobular carcinoma starts in parts of the breast, called lobules, that produce milk.
In rare cases, breast cancer can start in other areas of the breast.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Prognosis
- Symptoms
- Prevention
- Diagnosis
- Treatment for Cervical Intr...
- Treatment for Cervical Canc...
- Treatment for Invasive Cerv...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Human Papilloma Virus (HPV) Prevalence
About 25% of women age 14 - 59 are infected with the human papilloma virus (HPV), indicates a 2007 study in the Journal of the American Medical Association (JAMA). HPV prevalence is highest (45%) among women age 20 - 24. HPV is the main cause of cervical cancer.
- 1 Comment
Oct 08, 2008 -
Overview
- Signs and Symptoms
- What Causes It?
- Who's Most At Risk?
- What to Expect at Your Provider's Office
- Treatment Options
- Prognosis/Possible Complications
- Following Up
- Supporting Research
HEALTH GUIDE REFERENCE FROM A.D.A.M
Breast cancer is when a cancerous tumor occurs inside the breast. Each year more than 185,000 women are diagnosed with breast cancer. The incidence of this disease is rising in developed countries.
- 0 Comments
Oct 08, 2008 -
Overview
- Signs and Symptoms
- Causes
- Risk Factors
- Diagnosis
- Preventive Care
- Treatment
- Other Considerations
- Supporting Research
HEALTH GUIDE REFERENCE FROM A.D.A.M
Prostate cancer is a cancerous (malignant) tumor that originates in the prostate gland and can eventually spread to other organs, bones, and tissues. The prostate is a cluster of small glands located beneath the bladder that surrounds the urethra, the tube that carries urine from the bladder out through the penis. Its principle function is to manufacture fluid that constitutes a portion of the semen.
- 0 Comments